Filing Details
- Accession Number:
- 0000950170-25-006692
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-17 16:01:05
- Reporting Period:
- 2025-01-15
- Accepted Time:
- 2025-01-17 16:01:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1785173 | 89Bio Inc. | ETNB | Pharmaceutical Preparations (2834) | 831114349 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1792062 | Quoc Le-Nguyen | C/O 89Bio, Inc. 655 Montgomery Street, Suite 1500 San Francisco CA 94111 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-01-15 | 10,963 | $6.49 | 271,833 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on July 1, 2024.
- The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $6.36 to $6.60. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
